|
News
-
12.14.2023Perkins Coie Represents TRACT Therapeutics in Strategic Collaboration with Taiwan BioPress ReleasesPerkins Coie is pleased to have represented TRACT Therapeutics, a clinical stage biotechnology company, in its strategic collaboration deal to advance cellular therapy with Taiwan Bio, a one-stop, total solution cell therapy contract development and manufacturing organization.
-
07.11.2023Perkins Coie Advises Xentria in Multi-Year Licensing Agreement with Meitheal to Market Xentria’s Novel Biologic to Treat Pulmonary SarcoidosisPress ReleasesPerkins Coie is pleased to have advised Xentria Inc. in its exclusive multi-year licensing agreement with Meitheal Pharmaceuticals, Inc. to commercialize its novel biologic XTMAB-16 for pulmonary sarcoidosis in North America.
